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Abstract
Background In patients with severe forms of Parkinson’s
disease (PD), deep brain stimulation (DBS) commonly tar-
gets the subthalamic nucleus (STN). Recently, the mean 3-D
Morel-Atlas of the basal ganglia and the thalamus was
introduced. It combines information contained in histologi-
cal data from ten post-mortem brains. We were interested
whether the Morel-Atlas is applicable for the visualization
of stimulation sites.
Methods In a consecutive PD patient series, we documented
preoperative MRI planning, intraoperative target adjustment
based on electrophysiological and neurological testing, and
perioperative CT target reconstruction. The localization of
the DBS electrodes and the optimal stimulation sites were
projected onto the Morel-Atlas.
Results We included 20 patients (median age 62 years). The
active contact had mean coordinates Xlat=±12.1 mm, Yap=
−1.8 mm, Zvert=−3.2 mm. There was a significant differ-
ence between the initially planned site and the coordinates
of the postoperative active contact site (median 2.2 mm).
The stimulation site was, on average, more anterior and
more dorsal. The electrode contact used for optimal stimu-
lation was found within the STN of the atlas in 38/40 (95 %)
of implantations.
Conclusions The cluster of stimulation sites in individual
patients—as deduced from preoperative MR, intraoperative
electrophysiology and neurological testing—showed a high
degree of congruence with the atlas. The mean 3D Morel
Atlas is thus a useful tool for postoperative target visualiza-
tion. This represents the first clinical evaluation of the
recently created atlas.
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Introduction
Deep brain stimulation (DBS) has become a widespread ther-
apy for several neurological indications [4]. DBS has become
a standard treatment for patients with advanced Parkinson’s
disease (PD). For many patients, a site within the subthalamic
nucleus (STN) is chosen as an efficient target site to improve
motor symptoms [3, 5, 6, 22].
In surgical practice, the anatomical location of the STN in
individual PD patients is identified by several complementary
approaches: 1) Preoperatively, MR images are scanned for a
hypointense zone, which is caused by a susceptibility artefact
due to iron enrichment in the subthalamic area [21]. This zone
is used to identify the STN (“direct targeting” [2]). However,
this zone does not necessarily correspond to the anatomical
boundaries of the STN [12, 19]. 2) Intraoperatively, the loca-
tion of the STN is verified by stepwise electrophysiological
recording of neuronal activity with micro-electrodes. This
measurement features the highest specificity and provides a
spatial resolution in the submillimeter-scale along the elec-
trode trajectory. Furthermore, electrophysiological recording
shows a good correlation with the localization of STN in MR
[16]. 3) Intraoperative neurological testing in the awake pa-
tient documents undesired side effects and clinical efficacy of
the stimulation.
For postoperative documentation, stimulation sites in in-
dividuals can be projected on an atlas. There are a number of
two-dimensional atlases that use the intercommissural line
as a reference [11, 13, 17]. Since these atlases are based on
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brain slices, the spatial resolution is highly anisotropic: very
high within the slices and in the range of a millimeter in the
direction perpendicular to the slices. Furthermore, due to the
relatively small number of brains used for these atlases, a
bias towards an individual brain might occur. To overcome
these problems, the Yelnik group has constructed a three-
dimensional atlas from one brain [23], which can be de-
formed to adapt to each individual patient [1]. In a different
approach, a high-resolution, three-dimensional model of
thalamic and subthalamic structures (3D-Morel Atlas) was
recently constructed by combining information contained in
histological data from ten post-mortem brains [10].
In the current study, we projected the implanted electrodes
of a group of PD patients onto the 3D-Morel Atlas. We chose
PD patients because the individual patient’s STN can be
localized on the basis of radiological, electrophysiological
and neurological information. We use this information with
the dual aim to visualize the optimal stimulation sites and to
validate the applicability of the atlas for this purpose.
Methods
Patient inclusion criteria
We included all consecutive patients implanted with DBS
electrodes in the STN for the treatment of PD in 2010 and
2011. Collection of personal data and scientific workup was
approved by the institutional ethics review board (Kantonale
Ethikkommission E-50/2009), and all patients gave their
written informed consent. All surgeries were performed by
the last author (OS).
Preoperative imaging and target planning
We followed a standard procedure known as “image based
direct targeting“ [2]. Preoperative MR images were obtained
on a Philips Achieva 3T Scanner with the following two proto-
cols: T1W_3D_TFE (FOV AP 240 mm RL 240 mm FH
160 mm, Voxel size 1 mm x 1 mm x 1 mm, Slice orientation
transverse, Scan mode 3D, TE 6ms, TR 10ms, Flip angle 8°,
Scan duration 4:51 min) and T2W_3D_VISTA (FOV AP
240 mm RL 240 mm FH 160 mm, Voxel size 1 mm×1 mm×
1 mm, Slice orientation transverse, Scan mode 3D, TE 270ms,
TR 2500ms, Flip angle 90°, Scan duration 7:42 min). The scans
were fused using the StealthMerge algorithm on the Medtronic
Framelink Stealth Station (www.medtronic.com). Then ventric-
ular borders of the anterior and posterior commissures (AC, PC)
were determined to obtain the mid-commissural point (MCP).
Target planning was initiated at Xlat=±12 mm, Yap=−4 mm,
Zvert=−4 mm with respect to MCP, and then adapted to the
hypointense zones associated with the nucleus ruber (RN), the
substantia nigra (SN) and the STN in the MR images of the
individual patient.
Intraoperative procedures
Electrode penetration to target was guided by a stereotactic
frame (Riechert-Mundinger, www.inomed.de). We used up
to five electrodes with a distance of 2 mm between elec-
trodes (central, anterior, posterior, medial, lateral trajectory).
By micro-electrode recording (MER), we performed elec-
trophysiological recordings. An increase of MER back-
ground activity indicates the dorsal border of STN with
submillimeter accuracy. Thereafter, during test stimulation
through a macro-electrode, we performed a neurological
testing of the cardinal symptoms of PD and documented
side effects. On this basis, we determined the optimal site
for stimulation. Then, the neurosurgeon implanted the de-
finitive stimulation electrode (Medtronic Model 3389).
CT-based target reconstruction
After bilateral electrode implantation, we obtained a periop-
erative CT image to eliminate geometric image distortion
(Siemens Sensation 64, Spiral CT without gantry tilt, axial
scan reconstructed to slice thickness 1 mm). The CT image
was fused with the preoperative MRI scans using the
StealthMerge algorithm on the Medtronic Framelink
Stealth Station. We then reconstructed the localization of
the lowest contact of the stimulation electrode in AC-PC
coordinates and the angle from the mid-sagittal plane
(AMSP) and the angle from the axial plane (AFAP).
Clinical optimization of the stimulation site
After implantation, stimulation was started at the optimal
contact determined during intraoperative neurological test-
ing. In some patients, the stimulation was adapted to opti-
mize clinical impact and to reduce side effects. The stimu-
lation was optimized over a follow-up of at least 3 months.
We documented the contact that was finally selected for
stimulation.
The mean three-dimensional Morel Atlas
We present here a 3D version of the stereotactic Morel Atlas.
A detailed description of the atlas can be found in [10, 13]. In
brief, this atlas was constructed in the following way: 1) The
structures of interest were analysed in three planes orthogonal
to each other and oriented parallel or perpendicular to the
reference stereotactic plane passing through the centers of
AC and PC; 2) The delineation of structures based on
multiarchitectonic criteria provides a high histological resolu-
tion; and 3) The slices were provided at small and regular
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intervals. Furthermore, the atlas is based on histological data
taken from ten postmortem brains, which reduces the bias
towards a single brain. This results in a high-resolution,
three-dimensional model of the anatomical structures of
interest.
The STN of the 3D Morel Atlas compared with a recent MR
study
In a recent study, the anatomy of the STN in eight post mortem
tissue blocks was documented by high resolution MR with
histological validation [12]. For the maximal distance in the
axial plane from medial to lateral tip, these authors obtained a
mean of x=12 mm, compared to 8.9 mm in the mean atlas
used here. The maximal distance in axial plane between the
anterior and posterior borders perpendicular to the width
measurement was on average y=3.2 mm (3D Morel Atlas
5.5 mm). The maximal height obtained from the slices was on
average z=6.6 mm (3D Morel Atlas 5.7 mm). The STN is
oriented at approximately 40° to the midline (3D Morel Atlas
38°). This indicates that the mean STN volume used here has a
more rounded shape, probably due to the fact of averaging
over individual brains.
Projection of stimulation electrodes onto the 3D Morel Atlas
The stimulation electrode was projected onto to the atlas based
on the localization of its lowest contact and of the angles
AMSP and AFAP. The atlas and the electrode are represented
by digital objects in .vtk format that are handled by the Parallel
Visualization Application ParaView (www.paraview.org). The
atlas is constructed such that all structures of the right hemi-
sphere have been mirrored along the midsagittal plane.
Consequently, in our application of the atlas, electrodes im-
planted in the right subthalamic region have been mirrored
along the midsagittal plane to represent an electrode in the left
subthalamic region. Since the locations of left and right STN
are correlated in most patients, the left and right stimulation
sites in the same patient are not statistically independent.
Inter-individual variability in lateral direction
For the projection of coordinates of individual patients onto a
mean atlas, the inter-individual variability poses a major chal-
lenge. In our study, the atlas was not distorted so that the AC-
PC distance remained fixed to 26 mm. For the lateral direc-
tion, there is strong correlation between ventricular width and
the laterality of the hypointense zone reflecting the STN in
MR images [8]. Therefore, to account for the variability in
ventricular width of the patients’ brain, the atlas was shifted in
lateral direction for an alignment with the individual brain at
the thalamo-ventricular border.
Results
Patient population
We included 20 patients with L-dopa responsive idiopathic
PD (eight female, median age 62 years, range 42–76 years).
All patients were implanted bilaterally, resulting in a total of
40 electrode implantations.Median AC-PC length was 25mm
(range 22.6-27.6 mm). The median width of the third ventricle
was 4.3 mm (range 2.0 – 9.0 mm). Median duration of disease
was 11.5 years (range 1–19 years). Akinesia and rigidity were
present in all patients. Tremor was present in 17 patients; six
of them had a tremor-dominant form of PD. The median score
of Unified Parkinson’s Disease Rating Scale (UPDRS part III)
was 52 preoperatively (medication OFF) and improved to 15
postoperatively (medication ON, stimulation ON).
Intraoperative procedures
We tested all five electrode trajectories for six of the 40
electrode implantations (15 %). Four trajectories were tested
in five (13 %), and three in 11 (28 %) implantations. In about
half of the implantations, the number of trajectories tested was
restricted to one (nine cases, 28 %) and two trajectories (nine
cases, 28 %). Most frequently tested were central (all implan-
tations, 100 %) and medial (28/40 implantations, 70 %) tra-
jectories. Lateral (18/40, 45 %), anterior (14/40, 35 %), and
posterior (9/40 23 %) trajectories were less frequently chosen.
The use of trajectories was identical in left and right hemi-
spheres in 12/20 patients (60 %), differed by one trajectory in
6/20 patients, and by three trajectories in 2/20 patients.
The anterior trajectory was tested in 14 cases. The micro-
electrode recording indicated only a short passage through
STN (median 1.0 mm, range 0.0-6.5 mm). Neurological test-
ing ensued in only three cases and gave optimal results in one
patient only.
The final stimulation electrode (Medtronic Model 3389)
was implanted through the central trajectory in 24/40 im-
plantations (60 %), through the medial trajectory in 11/40
implantations (28 %), lateral and posterior two each (5 %)
and anterior in one implantation (3 %).
Postoperative reconstruction of stimulation sites
The average coordinates of all 40 active stimulation sites were
Xlat=12.1±1.3 mm (lateral), Yap=−1.8±1.4 mm (posterior of
MCP), Zvert=−3.2±1.3 mm (ventral of MCP) with AFAP=
56° and AMSP=26°. The median Euclidian distance (bias) to
the preoperatively determined target site wasΔ=2.2 mmwith
the median deviations Δ Xlat =0.2 mm, Δ Yap =1.4 mm, Δ
Zvert =0.7 mm. Thus, the optimal stimulation site, which was
determined in postoperative neurological testing, was more
dorsal than planned preoperatively. Constrained by the angle
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of the electrode trajectory, the optimal site was also more
anterior than planned preoperatively.
Projection of electrodes and optimal stimulation
sites onto the atlas
Figure 1A shows the atlas and a reconstructed electrode as
viewed from anterior. In this penetration, the electrode en-
ters the STN from antero-lateral at its dorso-lateral border in
the plane of the STN and exits ventrally.
We finally computed coordinates of the optimal stimula-
tion site as assessed by postoperative clinical testing. The
sites are represented in Fig. 2 for all 40 penetrations. While
the stimulating pole of the electrode has diameter 1.27 mm
and length 1.5 mm, we chose spheres of diameter 0.4 mm
for better visibility. Of the 40 penetrations, 38 (95 %)
showed the pole of optimal stimulation within or in direct
contact with the atlas’ STN (95 % confidence interval
[83.1–99.4 %]). All stimulating poles (100 %) were within
2 mm from STN, so that stimulation would modulate STN
activity at this distance [7]. The red cylinder in Fig. 2 depicts
the mean coordinates of the optimal stimulation sites in the
dorso-lateral STN.
Discussion
Inter-individual variability and the mean atlas
This study describes the mapping of anatomical information
of a group of 20 individual patient brains onto an atlas derived
from a group of ten brains. The variability in the 40 brain
hemispheres is accounted for at three levels. First, in the most
important step (“direct targeting” [2]), we set the target into
the hypointense zone in MR, which roughly corresponds to
the STN [12]. This target coordinate was then adjusted on the
basis of micro-electrode recording on one hand and neurolog-
ical testing on the other hand. We finally reconstructed the
coordinate of the sites of optimal stimulation based on post-
operative follow-up examinations at least 3 months after sur-
gery. Therefore, the individual stimulation sites contain ana-
tomical information on the individual patient’s brain hemi-
sphere. Over all patients, we obtain a distribution of optimal
stimulation sites (Fig. 2). The distribution is a cluster that is
narrow compared to the extent of the STN.
The improvement in UPDRS was not related to the
optimal stimulation site being situated within or outside
the atlas’ STN. We therefore assume that the deviation from
the atlas’ STN is not due to suboptimal surgical procedures,
Fig. 1 Projections of the quadripolar electrode onto the atlas. View of
an implanted electrode from anterior. Optimal stimulation was at the
second most dorsal contact. Electrode shaft (blue) and stimulation
contacts (red). Subthalamic Nucleus (STN, transparent green); Red
Nucleus (red); Thalamus (gray) with thalamic nuclei: Ventral
Anterior parvocellular division (VApc), Ventral Lateral anterior divi-
sion (VLa)
Fig. 2 Sites of optimal stimulation as determined in postoperative clin-
ical practice. View on the axial plane. Subthalamic Nucleus (STN, trans-
parent green); Red Nucleus (red); Mamillothalamic tract (blue) are
clipped at Zvert=−4 mm. All structures are mirrored to be depicted on
the left hemisphere. Since the location of left and right STN are, in
general, highly correlated, the left and right stimulation sites in the same
patient are not statistically independent. The cube is positioned at the site
where target planning was initiated (Xlat=±12 mm, Yap=−4 mm, Zvert=
−4 mm). Each sphere depicts the center of the optimal contact chosen for
stimulation in individual patients before correction for ventricular width.
The spheres are small (diameter=0.4 mm) for better visibility. The red
cylinder is centered on the mean of the coordinates of the optimal
stimulation site (Xlat=±12.1 mm, Yap=−1.7 mm, Zvert=−2.8 mm) and
oriented along the mean angles AFAP=56° and AMSP=26°. The di-
mensions of the cylinder correspond to that of a pole of Medtronic Model
3389 electrode (diameter 1.27 mm, height 1.5 mm)
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but reflects the individual variability of the patients, be it in
anatomy, age, disease duration or preoperative response to
levodopa [9].
Adaptation of the mean atlas to landmarks
Apart from MCP, which is used to align the atlas with the
patient’s brain, there are a number of landmarks, that are
known to correlate with selected features of the STN [8]. On
this basis, the Yelnik Atlas [23] is deformed to adapt to each
individual patient brain [1]. However, the correlation with
most landmarks is rather low [8] and each deformation of
the atlas introduces a new variable that must be justified. We
have therefore restricted ourselves to the parameter "ven-
tricular width", which is readily available and shows the
highest correlation (0.73) with STN laterality [8]. We ad-
justed for the ventricular width of the patients to normalize
the laterality of the STN.
Limitations in targeting, electrode placement
and reconstruction
There are several sources of error that may affect the accuracy
of the electrode placement and reconstruction. 1) Images from
3T MRI suffer from spatial distortions that may vary from
patient to patient, and which we did not correct for. 2) The
hypointense zone in MRI does not tightly correspond to the
STN [12, 19]. 3) There are mechanical tolerances in the
adjustment of the stereotactic frame. 4) We do not account
for distortions of local tissue in the target area due to the
insertion of electrodes. 5) The final stimulation electrode is
inserted through an empty trajectory under visual inspection
of x-ray images. This procedure may be affected by brain shift
due to mechanical strain and/or loss of cerebrospinal fluid.
The deviation between MR-target and reconstructed site may
thus be maximal during the perioperative CT and may dimin-
ish as cerebrospinal fluid is replenished. 6) The typical error in
CT-MR image fusion by the StealthMerge algorithm amounts
to 1.2 mm [15]. 7) Identification of the electrode tip on
volumetric CT scans has a spatial resolution that is limited
by the distance between CTslices. 8) Mirroring all sites on the
left hemisphere neglects that in most patients the geometry of
left and right hemisphere is correlated: The difference between
hemispheres in one patient (intra-individual variability) is
smaller than the differences between patients (inter-individual
variability).
Applicability of the mean atlas for target visualization
in STN
The 3D-Morel Atlas uses the mean to represent the distri-
bution of anatomical characteristics of the STN in ten brains.
Interestingly, the overlap between the distribution of
stimulation sites and the mean STN amounts to 95 % of
sites. This amounts to a high degree of congruence between
the atlas and information derived from image analysis of
MR and CT, intraoperative electrophysiology, and neuro-
logical testing. The STN volume in the atlas thus provides a
good representation of the STN in our patients, even though
we have adapted only for ventricular width. The accuracy is
certainly not sufficient to advocate atlas-based “indirect”
targeting. But all current approaches to reconstruct stimula-
tion sites show a more or less wide distribution [14, 18, 20,
23]. Our finding of the median of the optimal stimulation
sites in the dorso-lateral STN agrees with reports that stim-
ulation in the dorso-lateral STN [5, 22] improves motor
symptoms in PD patients.
Conclusions
The cluster of individual stimulation sites—as deduced from
preoperative MR, intraoperative electrophysiology and neu-
rological testing in PD patients—showed a high degree of
congruence with the atlas. Even with limited adaptation to
the individual patient’s brain, the mean 3DMorel Atlas is thus
a useful tool for postoperative visualization of the stimulation
electrode with respect to STN as the target. This represents the
first clinical evaluation of the recently created atlas.
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